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OBJECTIVES This study was designed to examine the effect of antioxidant supplementation on the
endothelial function and insulin sensitivity in patients with coronary spastic angina (CSA).
BACKGROUND Insulin resistance may play a key role in coronary heart disease, and there is a possible link
between acetylcholine-induced coronary vasoconstriction and hyperinsulinemia in patients
with CSA. Endothelial dysfunction is present in the systemic arteries in CSA patients, and
reactive oxygen species may cause inactivation of nitric oxide in these patients.
METHODS We measured flow-mediated dilation of the brachial artery using ultrasound technique in 22
patients with CSA and 20 control subjects. We also evaluated glucose tolerance using a 75-g
oral glucose tolerance test and insulin sensitivity using steady-state plasma glucose (SSPG)
methods in the same patients.
RESULTS The incidence of impaired glucose tolerance was higher in the CSA group than in the control
group. Vitamin C infusion augmented flow-mediated dilation and decreased SSPG levels in
the CSA group (from 3.27 6 0.77% to 7.00 6 0.59% [p , 0.001 by analysis of variance
(ANOVA)] and from 177.3 6 13.3 to 143.1 6 14.9 mg/dl [p 5 0.047 by ANOVA],
respectively) but not in the control group (from 6.47 6 0.66% to 6.80 6 0.60% and from
119.8 6 11.7 mg/dl to 118.1 6 11.3 mg/dl, respectively). The steady-state plasma insulin
levels were not affected by vitamin C infusion in either group.
CONCLUSIONS Vitamin C improves both endothelial function and insulin sensitivity in patients with CSA.
Thus, reactive oxygen species and/or decreased nitric oxide bioactivity may play an important
role in the genesis of both endothelial dysfunction and insulin resistance in patients with
CSA. (J Am Coll Cardiol 2000;35:1860–6) © 2000 by the American College of Cardiology
There is increasing evidence that insulin resistance plays an
important role in the pathogenesis of coronary heart disease
(1,2). Glucose intolerance, hypertension, obesity and dys-
lipidemia have been suggested to promote atherosclerosis,
with insulin resistance as the underlying intermediary (2,3).
Recent studies suggested that insulin resistance may also be
associated with coronary spasm (4–6). Endothelial dysfunc-
tion is an early and prominent event in atherogenesis (7). It
has been shown that acetylcholine (Ach) causes vasodilation
when the endothelium is intact by releasing nitric oxide
(NO), whereas it causes vasoconstriction when the endo-
thelium is removed or injured by directly acting on smooth
muscles (8). We have shown that Ach induces coronary
spasm in patients with coronary spastic angina (CSA) and
that both basal and NO activity are impaired in the coronary
artery of these patients (9–11).
Insulin has been shown to cause endothelium-dependent
vasodilation by releasing NO (12,13), and several studies
have revealed that endothelium-dependent vasodilation is
impaired in patients with insulin resistance (14,15). The
decreased endothelium-dependent vasodilation observed in
these patients may result from the inactivation of
endothelium-derived NO by reactive oxygen species (16),
and vitamin C, an antioxidant, is reported to improve
endothelium-dependent vasodilation in these patients
(17,18). Recently, noninvasive examination of endothelial
function has become possible using flow-mediated
endothelium-dependent dilation (FMD) of the brachial
artery during reactive hyperemia (19–21), and we have
shown that FMD of the brachial artery is impaired in
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patients with CSA (22,23). There are no reports, however,
whether FMD is improved in patients with CSA by vitamin
C. There are also no data on the possible role of antioxi-
dants in the genesis of insulin resistance.
The present study was designed to examine whether
vitamin C improves endothelial dysfunction and insulin
resistance in patients with CSA and without diabetes
mellitus compared with controls.
METHODS
Study subjects. We studied 22 patients with CSA (mean
age 55.6 6 3.1 years, 13 men and 9 women) in whom
episodes of spontaneous angina occurred at rest. All patients
with CSA had angiographically normal coronary arteries
and documented coronary spasm associated with ischemic
ST segment changes after the intracoronary injection of
Ach (9,10). The present study also included 20 control
subjects (mean age 57.1 6 1.8 years, 12 men and 8 women).
These control subjects were selected to match the cardio-
vascular risk factors (age, gender, smoking status, body mass
index, and hypertension) to those of the patients with CSA.
The control subjects underwent coronary catheterization for
evaluation of chest pain. They had angiographically normal
coronary arteries and did not have coronary spasm after the
intracoronary injection of Ach. Patients with diabetes mel-
litus, obesity (body mass index .26), familial hypercholes-
terolemia, previous myocardial infarction, congestive heart
failure or other serious diseases were excluded. Written,
informed consent was obtained from all subjects before the
study. The study was in agreement with the guidelines
approved by the ethics committee at our institution.
Oral glucose tolerance test. After the overnight fast, a
75-g oral glucose tolerance test (OGTT) was performed in
all subjects. Blood samples were drawn in the fasting state,
at 60 and 120 min after the glucose loading for determina-
tion of plasma glucose and insulin levels. The definition of
glucose tolerance was based on the World Health Organi-
zation criteria (24).
Measurements of insulin sensitivity. Insulin sensitivity
was estimated by the steady-state plasma glucose (SSPG)
methods with the use of Sandostatin (25). Sandostatin, an
analogue of somatostatin that inhibits the endogenous
secretion of insulin, glucagon and growth hormone, has a
longer duration of action than somatostatin and is more
potent than the natural compound (26). After the overnight
fast, Novolin R 40 insulin was injected in a bolus (7.5 mU/kg)
initially, and glucose (6 mg/kg/min) KCl (0.5 mEq/kg/min),
Novolin R 40 insulin (0.77 mU/kg/min) and Sandostatin
(150 mg/2 h) were infused simultaneously for 2 h through
an antecubital vein via a constant infusion pump. Blood
samples were obtained at 0 and 120 min for the determi-
nation of plasma glucose and insulin. Steady-state plasma
glucose and steady-state plasma insulin (SSPI) concentra-
tions were obtained at 120 min. Under these steady-state
conditions, plasma glucose was inversely correlated with the
rate of insulin-mediated glucose disposal and was inversely
proportional to insulin sensitivity (27).
Measurements of FMD of the brachial artery. The mea-
surement of the brachial artery diameter was performed
using the ultrasound technique as described in our previous
studies and by others (19–23). The subjects lay quietly for at
least 10 min before the first scan. The brachial artery was
scanned in the antecubital fossa in a longitudinal fashion.
Gain setting was optimized at the beginning of the study
and was kept constant throughout the recording period.
When a satisfactory transducer position was found, the arm
remained at the same position throughout the study. The
diameter of the brachial artery was measured from B-mode
ultrasound images with a 7.5-MHz linear array transducer
(SSH-160A; Toshiba, Tokyo, Japan). The flow velocity of
the brachial artery was measured with a pulsed Doppler
signal at a 70-degree angle to the vessel, with the range gate
(1.5 mm) in the center of the artery. After the baseline
measurements of the diameter and the flow velocity in the
brachial artery, a blood-pressure cuff placed around the
forearm was inflated with a pressure of 250 to 300 mm Hg.
After 5 min, the cuff was deflated. During the cuff inflation
and deflation, diameter and flow velocity were measured
continuously. Images were recorded on a super-VHS vid-
eocassette recorder (BR-S 601M; Victor, Tokyo, Japan),
and the brachial arterial diameters were measured from the
tape with ultrasonic calipers. The measurements were per-
formed by two independent observers who were blinded as
to which group the individual belonged to or from which
infusion the images had acquired.
In our study, the interobserver variability for the repeated
measurements of resting arterial diameter was 0.05 6
0.02 mm. The intraobserver variability for the repeated
measurements of resting arterial diameter was 0.02 6
0.02 mm. In a preliminary study, when these procedures
were performed at the same time on two separate days in 20
volunteers, the average intrasubject test-retest difference for
the measurements of the arterial diameter during the reac-
tive hyperemia was 0.05 6 0.04 mm.
Vitamin C infusion protocol. Vitamin C (ascorbic acid;
Takeda, Osaka, Japan) was administered via the antecubital
Abbreviations and Acronyms
Ach 5 acetylcholine
ANOVA 5 analysis of variance
CSA 5 coronary spastic angina
FMD 5 flow-mediated dilation
HDL 5 high-density lipoprotein
NO 5 nitric oxide
OGTT 5 oral glucose tolerance test
SSPG 5 steady-state plasma glucose
SSPI 5 steady-state plasma insulin
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vein. Vitamin C was infused at a constant dose of 10
mg/min to limit the total vitamin C dose to ,2,000 mg.
Experimental protocol. The experimental protocols were de-
signed as two-day protocols (Fig. 1). On the first day, FMD
was examined during saline infusion used as a placebo, and
thereafter an insulin sensitivity test was performed in the
morning in the fasting state. On the second day, FMD was
examined 30 min after the initiation of saline plus vitamin C
infusion. Then, the insulin sensitivity test was started sequen-
tially under concomitant infusion of saline plus vitamin C.
Blood sampling for concentration of vitamin C was done 0, 30
(at the start of the insulin sensitivity test), 60 and 150 min (at
the termination of the insulin sensitivity test) after the initia-
tion of saline plus vitamin C infusion.
All medications except sublingual nitroglycerin were
withdrawn at least three days before the study. No patients
had taken nitroglycerin within 6 h before the study. Blood
pressure and heart rate were monitored during the study.
Analysis of blood samples. Plasma concentration of glu-
cose was measured by the glucose oxidase method, and
insulin by radioimmunoassay. Vitamin C concentration was
measured by high-performance liquid chromatography (28).
Statistics analysis. The clinical characteristics were com-
pared between the two groups by using the unpaired t test
for continuous data and the chi-square test for group data.
The changes in variables were assessed by two-way analysis
of variance (ANOVA) with repeated measures followed by
post-hoc testing with Scheffe’s test. Correlations with
FMD, SSPG and vitamin C levels were examined using
linear regression analysis. Statistical significance was defined
as p , 0.05. Data were expressed as mean 6 standard error
of the mean.
RESULTS
Baseline characteristics and oral glucose tolerance test.
There were no differences in the baseline characteristics
between the CSA group and the control group except for
the incidence of impaired glucose tolerance and the plasma
levels of high-density lipoprotein (HDL)-cholesterol, as
shown in Table 1. The incidence of impaired glucose
tolerance was higher in the CSA group than in the control
group. The HDL cholesterol levels were lower in the CSA
patients than in the control subjects.
Figure 1. Schematic representation of the experimental protocol. RH 5 analysis of reactive hyperemia; SSPG 5 steady-state plasma
glucose.
Table 1. Patient Characteristics
CSA
(n 5 22)
Control
(n 5 20)
p
Values
Gender 0.800
Men 13 (59.1%) 12 (60.0%)
Women 9 (40.9%) 8 (40.0%)
Age, years 55.6 6 3.1 57.1 6 1.8 0.661
Smoker 13 (59.1%) 9 (45.0%) 0.361
IGT 9 (40.9%) 2 (10.0%) 0.023
Hypertension 5 (22.7%) 4 (20.0%) 0.830
Body mass index
(kg/m2)
23.6 6 0.8 23.6 6 0.9 0.980
Total cholesterol
(mg/dl)
188.4 6 6.6 198.1 6 11.8 0.736
HDL cholesterol
(mg/dl)
45.2 6 3.0 55.1 6 3.5 0.028
LDL cholesterol
(mg/dl)
113.5 6 7.0 118.3 6 9.5 0.678
Triglyceride
(mg/dl)
146.1 6 17.2 123.4 6 13.0 0.266
CSA 5 coronary spastic angina; HDL 5 high-density lipoprotein; IGT 5 impaired
glucose tolerance; LDL 5 low-density lipoprotein.
Values are expressed as mean 6 SE.
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Plasma glucose and insulin responses to OGTT are
shown in Table 2. The fasting insulin levels were higher in
the CSA group than in the control group, whereas there was
no difference between the two groups in the fasting glucose
levels. The glucose levels at 60 and 120 min were higher in
the CSA group than in the control group. The insulin levels
at 60 and 120 min were also higher in the CSA group than
in the control group.
The basal vitamin C levels were lower in the CSA group
than in the control group, as shown in Table 3. The levels
increased in both groups after vitamin C infusion, and there
were no differences in the levels during the infusion time
between the two groups.
Response of FMD to vitamin C. The baseline hemody-
namics parameters were not different between the two
groups. There was also no difference in the arterial diameter
(control: 4.26 6 0.14, CSA: 4.26 6 0.17 mm, p 5 0.979,
NS), the blood flow or the increases in blood flow during
reactive hyperemia between the two groups at the baseline.
However, FMD was reduced in the CSA group at the
baseline (3.27 6 0.77 vs 6.47 6 0.66%, p , 0.001).
Vitamin C infusion did not affect hemodynamics param-
eters, the arterial diameter, the blood flow or the increases in
blood flow during reactive hyperemia. However, vitamin C
infusion augmented FMD in the CSA group (from 3.27 6
0.77% to 7.00 6 0.59%, p , 0.001) but not in the control
group (from 6.47 6 0.66 to 6.80 6 0.60%, p 5 0.804, NS).
The differences of FMD between the CSA group and the
control group analyzed by two-way ANOVA were signifi-
cant (p 5 0.048). Those of FMD between the saline
infusion and the saline plus vitamin C infusion analyzed by
two-way ANOVA were also significant (p , 0.001). The
effect of vitamin C on FMD in the CSA group was
significantly different from that in the control group, as
shown in Figure 2 (p , 0.001, by ANOVA).
Response of SSPG to vitamin C. There were no changes
in hemodynamics during the insulin sensitivity test. The
baseline SSPG levels were higher in the CSA group than in
the control group (177.3 6 13.3 vs. 119.8 6 11.7 mg/dl,
p , 0.001). There was no difference in the baseline SSPI
levels between the two groups (38.7 6 4.0 vs. 35.2 6 3.2 U/ml,
p 5 0.494, NS).
Vitamin C infusion decreased the SSPG levels in the
CSA group (from 177.3 6 13.3 to 143.1 6 14.9 mg/dl, p 5
0.013) but not in the control group (from 119.8 6 11.7 mg/dl
to 118.1 6 11.3 mg/dl, p 5 0.967, NS). The differences of
SSPG between the CSA group and the control group
analyzed by two-way ANOVA were significant (p 5 0.017).
Those of SSPG between the saline infusion and the saline
plus vitamin C infusion analyzed by two-way ANOVA were
also significant (p 5 0.008). The effect of vitamin C on the
SSPG levels in the CSA group was significantly different
from those in the control group, as shown in Figure 3 (p 5
0.047, by ANOVA). The SSPI levels were not affected by
vitamin C infusion in either group.
Correlation between FMD and vitamin C levels and that
between SSPG and vitamin C levels. There was a positive
correlation between FMD and the vitamin C levels at
baseline (r 5 0.472, p , 0.001), as shown in Figure 4A.
There was a negative correlation between the SSPG levels
and the vitamin C levels at baseline (r 5 20.469, p 5
0.002) (Fig. 4B). Both correlations disappeared after vita-
Figure 2. Effect of vitamin C on flow-mediated dilation in
patients with coronary spastic angina and in control subjects. See
text for details. Data are expressed as mean value 6 SE. **Signif-
icant effect of vitamin C infusion on the CSA group compared
with the control group, p , 0.001 by ANOVA. CSA 5 coronary
spastic angina.
Table 2. Oral Glucose Tolerance Test
CSA
(n 5 22)
Control
(n 5 20) p Values
Glucose
Fasting (mg/dl) 91.8 6 2.0 94.4 6 2.6 0.798
60 min (mg/dl) 177.5 6 9.8 142.3 6 8.8 0.012
120 min (mg/dl) 135.3 6 5.2 113.9 6 6.8 0.013
Insulin
Fasting (mU/ml) 9.2 6 0.5 7.1 6 0.4 0.001
60 min (mU/ml) 85.9 6 12.0 53.1 6 6.1 0.012
120 min (mU/ml) 56.6 6 5.8 37.8 6 4.5 0.015
CSA 5 coronary spastic angina.
Values are expressed as mean 6 SE.
Table 3. Plasma Vitamin C Concentration
CSA (n 5 22) Control (n 5 20) p Values
0 min 34.6 6 3.4 48.3 6 4.5 0.023
30 min 180.6 6 17.6 234.0 6 23.3 0.092
60 min 245.9 6 26.1 280.6 6 26.1 0.365
150 min 355.6 6 31.2 388.5 6 28.4 0.752
CSA 5 coronary spastic angina.
Values (mmol/liter) are expressed as mean 6 SE.
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min C administration (r 5 0.113, p 5 0.576, NS, r 5
20.381, p 5 0.073, NS, respectively).
Correlation between SSPG and FMD. There was a
negative correlation between the SSPG levels and FMD
(r 5 20.492, p 5 0.002), as shown in Figure 5. The
correlation disappeared after vitamin C infusion (r 5 0.008,
p 5 0.971, NS).
DISCUSSION
Recent studies have shown that FMD of the brachial artery
during reactive hyperemia is endothelium (20–23) and NO
dependent (19). The present study showed that FMD of the
brachial artery was decreased in the patients with CSA
compared with controls. The study also showed that the
plasma levels of vitamin C were decreased, and there was a
positive correlation between the vitamin C levels and FMD
at baseline. Flow-mediated dilation or the endothelial dys-
function was improved, and the significant correlation
between FMD and plasma vitamin C levels disappeared
after treatment of vitamin C, an antioxidant, in these
patients. We have shown previously that endothelium-
dependent dilations of both the coronary artery and the
brachial artery were impaired in patients with CSA and that
these impairments were improved by treatment with anti-
oxidants, vitamin C and vitamin E in these patients (22,29).
The present study, thus, confirms the results of our previous
studies.
We also demonstrate that insulin sensitivity as assessed by
the levels of SSPG and levels of fasting plasma insulin was
impaired in patients with CSA compared with controls.
These results are in agreement with those of the previous
studies (4–6). In addition, the present study showed that
there was a negative correlation between the SSPG and the
vitamin C levels at baseline, and the elevated SSPG levels or
the impairment of insulin sensitivity was improved along
with FMD or a marker of endothelial function by the
vitamin C supplementation. There was a negative correla-
tion between the SSPG levels and FMD at baseline.
However, the correlation disappeared after administration
of vitamin C, probably because vitamin C eliminated the
effects of reactive oxygen species. Thus, the present study
shows for the first time that there is a close correlation
between endothelial function and insulin sensitivity and that
reactive oxygen species play an important role in the genesis
of insulin resistance as well as endothelial dysfunction.
Increased reactive oxygen species inactivate endothelial NO
and lead to endothelial dysfunction (16,30). Endothelium plays
an important role in the regulation of blood flow to insulin-
sensitive tissues, and insulin induces endothelium-dependent
Figure 3. Effect of vitamin C on steady-state plasma glucose in
patients with coronary spastic angina and in control subjects. See
text for details. Data are expressed as mean value 6 SE. *Signif-
icant effect of vitamin C infusion on the CSA group compared
with the control group, p , 0.05 by ANOVA. CSA 5 coronary
spastic angina; SSPG 5 steady-state plasma glucose.
Figure 4. Correlation between: (A) plasma vitamin C concentra-
tion and flow-mediated dilation, and that between (B) vitamin C
concentration and steady-state plasma glucose before vitamin C
infusion. SSPG 5 steady-state plasma glucose.
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vasodilation (12,13). Impaired insulin-induced increase in
skeletal muscle blood flow has been reported in insulin resis-
tance states, including obesity, hypertension and type 2 diabe-
tes mellitus (31). It is thus possible that reactive oxygen species
cause endothelial dysfunction, which may contribute to insulin
resistance through impaired delivery of insulin to the insulin-
sensitive tissues such as skeletal muscles. Other studies, how-
ever, have reported that insulin resistance may occur in the
absence of reduced blood flow in skeletal muscles (32,33). It is
possible that reactive oxygen species may cause flow-
independent insulin resistance by inhibiting insulin receptor
signaling.
The sources of increased reactive oxygen species are not
clear. We and others have shown that cigarette smoking is
a highly significant risk factor for coronary spasm (34–37)
and that cigarette smoke extracts contain large amounts of
reactive oxygen species that cause endothelial dysfunction
(30,38). We have also shown that patients with CSA are
significantly associated with mutations of endothelial NO
synthase gene (36,37), which may lead to reduced endothe-
lial production of NO and thus reduced scavenging of
reactive oxygen species. These factors may play important
roles in the production of increased reactive oxygen species
in patients with CSA.
High-density lipoprotein-cholesterol is known as an an-
tioxidant (39), and its plasma levels were decreased in the
CSA group compared with the control group in the present
study. We previously reported that, in the patients with
CSA, the oxidative stress increased compared with the
control subjects (22). Thus, there may be a close relationship
between the increased reactive oxygen species and HDL
cholesterol levels in patients with CSA.
Recently, ascorbic acid has been shown to potentiate NO
synthesis in endothelial cells through improvement of cel-
lular redox state or glutathione metabolism (20,40,41).
Furthermore, Jackson et al. reported that normal extracel-
lular concentrations of ascorbic acid (30 to 150 mmol/liter)
are not likely to prevent the interaction of NO with
superoxide under physiological condition (41). In the
present study, the plasma vitamin C concentrations were
lower in the patients with CSA than in the control subjects.
Thus, another possible mechanism of the present results
may be that a deficiency of vitamin C decreased NO
synthesis in patients with CSA.
Study limitations. In the present study, we examined
FMD of the brachial artery as a marker of endothelial
function. However, endothelial dysfunction at the arteriolar
and capillary levels may be metabolically more important in
relation to insulin resistance (42). However, atherosclerosis
is a disease of large conduit arteries and insulin resistance is
associated with risk factors of atherosclerosis, including
hypertension, dyslipidemia, type 2 diabetes and obesity (43).
It is thus quite probable that the endothelium of both large
conduit arteries and resistance vessels are impaired by
increased reactive oxygen species in patients with coronary
risk factors, including those with CSA.
In conclusion, both FMD of the brachial artery and
insulin sensitivity as assessed by SSPG levels are impaired in
patients with CSA, and these impairments are improved by
the administration of vitamin C. The results indicate that
there is a close relationship between endothelial function
and insulin sensitivity and that increased reactive oxygen
species and/or decreased NO bioactivity may play an im-
portant role in the genesis of both endothelial dysfunction
and insulin resistance in patients with CSA.
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